| Date | Title | Description | Source |
| 18.10.2023 | Wegovy doesn’t work for everyone, and no one’s quite sure wh... | Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech ne... | statnews.c... |
| 27.01.2022 | BrainStorm Cell Therapeutics to Present at the 12th Annual C... | NEW YORK, Jan. 27, 2022 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading ... | marketscre... |
| 04.01.2022 | BrainStorm Cell Therapeutics to Present at Biotech Showcase™... | NEW YORK, Jan. 4, 2022 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading d... | marketscre... |
| 27.12.2021 | FDA Authorizes Further NurOwn® Dosing Under Expanded Access ... | NEW YORK, Dec. 27, 2021 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading ... | marketscre... |
| 13.12.2021 | BrainStorm Cell Therapeutics Announces peer reviewed publica... | NEW YORK, Dec. 13, 2021 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading ... | marketscre... |
| 07.12.2021 | BrainStorm Cell Therapeutics and Catalent Announce Completio... | NEW YORK and SOMERSET, N.J., Dec. 7, 2021 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ:... | marketscre... |
| 02.12.2021 | BrainStorm Cell Therapeutics to Present New Biomarker Data o... | NEW YORK, Dec. 2, 2021 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading d... | marketscre... |
| 29.11.2021 | BrainStorm Cell Therapeutics Announces the Presentation of N... | NEW YORK, Nov. 29, 2021 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading ... | marketscre... |
| 15.11.2021 | BrainStorm Cell Therapeutics Announces Third Quarter 2021 Fi... | NEW YORK, Nov. 15, 2021 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading ... | marketscre... |
| 15.11.2021 | BRAINSTORM CELL THERAPEUTICS INC. Management's Discussion an... | Company Overview
BrainStorm Cell Therapeutics Inc. is a leading biotechnology company committed to ... | marketscre... |
| 08.11.2021 | BrainStorm Cell Therapeutics Expands Leadership Team to Supp... | NEW YORK, Nov. 8, 2021 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading d... | marketscre... |
| 08.11.2021 | BrainStorm Cell Therapeutics Expands Leadership Team to Supp... | NEW YORK, Nov. 8, 2021 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading d... | salamancap... |
| 28.10.2021 | Brainstorm Cell Therapeutics Announces Appointment of Menghi... | NEW YORK, Oct. 28, 2021 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading ... | marketscre... |
| 18.10.2021 | Brainstorm Cell Therapeutics : Announces Scientific Presenta... | NEW YORK, Oct. 18, 2021 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading ... | marketscre... |
| 14.10.2021 | Brainstorm Cell Therapeutics : Phase 2 Clinical Trial Data o... | NEW YORK, Oct. 14, 2021 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading ... | marketscre... |
| 07.10.2021 | Brainstorm Cell Therapeutics : to Present ALS Phase 3 Biomar... | NEW YORK, Oct. 6, 2021 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading d... | marketscre... |
| 04.10.2021 | Brainstorm Cell Therapeutics : to Present at the 2021 Cell &... | NEW YORK, Oct. 4, 2021 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading d... | marketscre... |
| 01.10.2021 | BrainStorm to Present Phase 2 Progressive MS Study Results i... | NEW YORK, Oct. 1, 2021 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading d... | marketscre... |
| 05.08.2021 | BrainStorm Announces Second Quarter 2021 Financial Results a... | NEW YORK, Aug. 5, 2021 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading d... | salamancap... |
| 05.08.2021 | Brainstorm Cell Therapeutics : Announces Second Quarter 2021... | NEW YORK, Aug. 5, 2021 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading d... | marketscre... |
| 05.08.2021 | BrainStorm Announces Second Quarter 2021 Financial Results a... |
NEW YORK, Aug. 5, 2021 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading... | prnewswire... |
| 05.08.2021 | BRAINSTORM CELL THERAPEUTICS : Management's Discussion and A... | Company Overview
BrainStorm Cell Therapeutics Inc. is a leading biotechnology company committed to ... | marketscre... |
| 27.07.2021 | Brainstorm Cell Therapeutics : Increases Commercial Manufact... | NEW YORK, July 27, 2021 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading ... | marketscre... |
| 27.07.2021 | BrainStorm Increases Commercial Manufacturing Capacity; Gran... |
NEW YORK, July 27, 2021 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leadin... | prnewswire... |
| 15.06.2021 | BRAINSTORM CELL THERAPEUTICS INC.
Brainstorm Cell Therapeut... | NEW YORK, June 15, 2021 /PRNewswire/ -- Brainstorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading ... | marketscre... |
| 15.06.2021 | Brainstorm Announces Expansion of NurOwn® IP Portfolio with ... |
NEW YORK, June 15, 2021 /PRNewswire/ -- Brainstorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leadin... | prnewswire... |
| 25.05.2021 | BRAINSTORM CELL THERAPEUTICS INC.
Brainstorm Cell Therapeut... | NEW YORK, May 25, 2021 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading d... | marketscre... |
| 25.05.2021 | BrainStorm Announces Scientific Presentation of NurOwn® Exos... |
NEW YORK, May 25, 2021 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading... | prnewswire... |
| 26.04.2021 | BRAINSTORM CELL THERAPEUTICS INC.
Brainstorm Cell Therapeut... | Table of Contents
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
... | marketscre... |
| 26.04.2021 | BRAINSTORM CELL THERAPEUTICS INC.
BRAINSTORM CELL THERAPEUT... | Company Overview
BrainStorm Cell Therapeutics Inc. is a leading biotechnology company committed to ... | marketscre... |
| 26.04.2021 | BRAINSTORM CELL THERAPEUTICS INC.
Brainstorm Cell Therapeut... | NEW YORK, April 26, 2021 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading... | marketscre... |
| 26.04.2021 | BrainStorm Announces First Quarter 2021 Financial Results an... | NEW YORK, April 26, 2021 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading... | salamancap... |
| 26.04.2021 | Brainstorm Cell Therapeutics : Quarterly Report (SEC Filing ... | Table of Contents
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
... | marketscre... |
| 26.04.2021 | BrainStorm Announces First Quarter 2021 Financial Results an... |
NEW YORK, April 26, 2021 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leadi... | prnewswire... |
| 19.04.2021 | BrainStorm to Announce First Quarter Financial Results and P... | NEW YORK, April 19, 2021 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading... | salamancap... |
| 24.03.2021 | BrainStorm Announces Positive Topline Data in Phase 2 Study ... |
NEW YORK, March 24, 2021 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leadi... | prnewswire... |
| 22.02.2021 | Despite red flag from FDA, controversial ALS cell thera... | When BrainStorm Cell Therapeutics broke out the abysmal numbers in its Phase III trial, the bi... | endpts.com... |
| 22.02.2021 | BrainStorm Announces High-Level FDA Feedback on NurOwn® ALS ... |
NEW YORK, Feb. 22, 2021 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leadin... | prnewswire... |
| 09.02.2021 | BrainStorm Announces Feedback from FDA Type-C Meeting on Fut... |
NEW YORK, Feb. 9, 2021 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading... | prnewswire... |
| 04.02.2021 | BrainStorm Announces Full Year 2020 Financial Results and Pr... |
NEW YORK, Feb. 4, 2021 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading... | prnewswire... |
| 20.01.2021 | BrainStorm Announces the Publication of Preclinical Data Hig... |
NEW YORK, Jan. 20, 2021 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leadin... | prnewswire... |
| 18.12.2020 | BrainStorm Announces Completion of All Dosing in NurOwn® Pha... |
NEW YORK, Dec. 18, 2020 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leadin... | prnewswire... |
| 14.12.2020 | BrainStorm Announces NurOwn® Expanded Access Program
USA - ... |
NEW YORK, Dec. 14, 2020 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leader... | prnewswire... |
| 23.11.2020 | BrainStorm to present NurOwn® Phase 3 Clinical Trial Results... |
NEW YORK, Nov. 23, 2020 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leadin... | prnewswire... |
| 17.11.2020 | BrainStorm Announces Topline Results from NurOwn® Phase 3 AL... |
NEW YORK, Nov. 17, 2020 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leadin... | prnewswire... |
| 26.10.2020 | Rapid Reshore & Development and BrainStorm Cell Therapeu... |
PHILADELPHIA and NEW YORK, Oct. 26, 2020 /PRNewswire/ -- Rapid Reshore & Development (RR&D... | prnewswire... |
| 19.10.2020 | BrainStorm Announces Scientific Presentation of NurOwn® Exos... |
NEW YORK, Oct. 19, 2020 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leadin... | prnewswire... |
| 15.10.2020 | BrainStorm Announces Financial Results for the Third Quarter... |
NEW YORK, Oct. 15, 2020 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leadin... | prnewswire... |
| 30.09.2020 | BrainStorm Announces Scientific Presentation at the Annual N... |
NEW YORK, Sept. 30, 2020 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leadi... | prnewswire... |
| 29.09.2020 | BrainStorm Appoints William K. White as Senior Vice Presiden... |
NEW YORK, Sept. 29, 2020 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leadi... | prnewswire... |
| 16.09.2020 | Brainstorm Announces Grant of a New Japanese Patent for NurO... |
NEW YORK, Sept. 16, 2020 /PRNewswire/ -- Brainstorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leadi... | prnewswire... |
| 25.08.2020 | BrainStorm to Present Data Linking MRI Measures to Functiona... |
NEW YORK, Aug. 25, 2020 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leadin... | prnewswire... |
| 19.08.2020 | BrainStorm Announces Publication of New Preclinical Data Sup... |
NEW YORK, Aug. 19, 2020 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leadin... | prnewswire... |
| 07.09.2018 | Ovid exec Yaron Werber crosses back to Cowen; Saqib Isla... | Yaron Werber
→ While a number of analysts have been seen migrating to the front lines of biot... | endpts.com... |
| 04.09.2018 | Brainstorm recruits Novartis vet Araya as chief commer... | → BrainStorm Cell Therapeutics $BCLI has appointed Novartis vet Arturo Araya as chief comm... | endpts.com... |
| 18.07.2016 | Brainstorm’s rally fizzles after investors turn sour on... | Brainstorm Cell Therapeutics worked hard Monday morning to make the case that a small Phase II... | endpts.com... |
